NORAD and neoplasm: In contrast, CDDP induced significant regression in tumours derived from KYSE30/CDDP-R cells pretreated with sh-NORAD beginning in the 4th week, indicating that NORAD knockdown partly reversed CDDP resistance (Fig. 7a).